Bioequivalence of Estradiol 10 mcg Vaginal Tablets in Healthy Women Participants.
- Registry ID
- 2026-526477-42-00
- Source registry
- CTIS
- Status
- Authorised
- Phase
- PHASE1
- Study type
- INTERVENTIONAL
- Sponsor
- Laboratorios Leon Farma S.A.
- Enrollment
- 48
- Last update
- 2026-08-14
Conditions
- Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
- Not applicable (submitted trial is a bioavailability trial in healthy participants).
Locations
Related clinical trials
- A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants
- A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Subjects with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)
- An Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Difelikefalin in Adolescents Aged 12 to 17 Years on Haemodialysis with Moderate-to-Severe Pruritus (KOR-PED-202)
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Povetacicept in Adults with Immunoglobulin A Nephropathy (RAINIER).
- MERCURE study: MEthotrexate in ReCurrent dVIN
- A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab with Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) with Moderately to Severely Active Crohn's Disease
View on source registry